Ananthi Anandhakrishnan
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Adults with type 1 diabetes define what matters to them in stem-cell derived islet cell therapy.
Journal: Nature medicine
Published: February 18, 2026
Discordant real-world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter.
Journal: Diabetes, obesity & metabolism
Published: December 03, 2025
Hybrid closed-loop systems in UK type 1 diabetes care: National survey of healthcare professional awareness, confidence, and training needs.
Journal: Diabetes, obesity & metabolism
Published: June 30, 2025
Ethnicity and socioeconomic status do not influence glycaemic outcomes of a tubeless hybrid closed-loop system (Omnipod® 5) in adults with type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 24, 2025
Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes.
Journal: Diabetes, obesity & metabolism
Published: July 06, 2024
How COVID-19 has changed the unselected medical take: an observational study.
Journal: Clinical medicine (London, England)
Published: September 23, 2020
How to refer to people with disease in research outputs: The disconnection between academic practise and that preferred by people with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: July 11, 2016
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.
Journal: World journal of diabetes
Published: June 14, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026